68
Pharmosa Biopharm Inc.
6875.TWO · TWO
$31.05 -2.97% (-$0.95)
1M -0.78%
Market Cap $4.15B
P/E Ratio -
Div. Yield -
ROE 23.20%
Piotroski F-Score Weak
1/9Valuation
33 /100
Expensive P/B 3.04x
P/S 77.68x
EV/FFO N/A
Growth
100 /100
Growing Book val. growth 26.97%
Rev. growth N/A
FCF growth N/A
Profitability
0 /100
Weak Net margin 658.14%
Op. margin 762.03%
FCF margin 935.21%
Quality
0 /100
Poor ROE 23.20%
ROA 19.71%
Asset turnover 0.03x
Debt
69 /100
Low Current ratio 12.45x
Int. coverage -148.64x
Debt/Equity 0.25x
Stability
1 /100
Unstable EPS volatility 1,078.95%
Profitable years 0
Beta 0.19x
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre 6875.TWO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Pei Kan
Employees
15
Headquarters
Taipei City